Trexa Tablet 250mg

Manufacturer
DUOPHARMA HAPI SDN. BHD.(MALAYSIA)

Registraction Number
MAL22036014AZ

Content:
Trexa Tablet 250mg contains 250 mg of gefitinib, which is a tyrosine kinase inhibitor used to treat non-small cell lung cancer (NSCLC). Gefitinib works by blocking the activity of the epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells.
Indications:

• Non-Small Cell Lung Cancer (NSCLC): Treatment of patients with locally advanced or metastatic NSCLC with EGFR exon 19 deletions or exon 21 (L858R) substitution mutations.

1. Administration: Take orally, as directed by your doctor.
2. Dosage: The recommended dosage is 250 mg once daily, taken on an empty stomach (at least 1 hour before or 2 hours after a meal).
3. Timing: Take it at the same time each day to help you remember.
4. Monitoring: Regular monitoring of blood counts and other parameters is essential.